Interpret the patient's laboratory panel showing normal electrolytes, renal function (eGFR > 60 mL/min/1.73 m²), glucose, calcium, bilirubin, total protein, albumin, a mildly elevated aspartate aminotransferase (AST 37 IU/L) with normal alanine aminotransferase (ALT 19 IU/L), and low alkaline phosphatase (38 IU/L).

Laboratory Panel Interpretation

This laboratory panel is essentially reassuring and requires no immediate intervention, though the mildly elevated AST and low alkaline phosphatase warrant brief consideration in clinical context.

Overall Assessment

The patient's laboratory results demonstrate normal organ function across all major systems 1:

• Renal function: Normal with eGFR >60 mL/min/1.73 m² using the recommended 2021 CKD-EPI creatinine equation, which provides better prediction of clinical outcomes than previous equations 2, 3
• Electrolytes and acid-base status: All within normal limits, indicating stable homeostasis 1
• Hepatic synthetic function: Normal albumin (4.8 g/dL) and total protein (7.9 g/dL), indicating preserved liver synthetic capacity 1
• Metabolic status: Normal fasting glucose (73 mg/dL) and calcium (9.6 mg/dL) 4

Liver Enzyme Pattern Analysis

Mildly Elevated AST (37 IU/L, reference 11-34)

The isolated mild AST elevation of 37 IU/L with normal ALT (19 IU/L) is clinically insignificant and does not indicate liver disease 1:

• The AST/ALT ratio is approximately 1.95, which in isolation might suggest consideration of alcohol-related liver disease or advanced fibrosis, but this interpretation is invalid when both values are near-normal or only minimally elevated 5
• According to current guidelines, the extent of liver enzyme abnormality does not necessarily correlate with clinical significance—diagnosis and clinical context are paramount 1
• Normal bilirubin (0.6 mg/dL), albumin, and total protein confirm absence of hepatic dysfunction 1
• AST can be elevated from non-hepatic sources including muscle, cardiac tissue, and red blood cells 1

Low Alkaline Phosphatase (38 IU/L, reference 40-150)

The mildly low alkaline phosphatase has no clinical significance and requires no action 6:

• Low ALP is generally benign and not associated with adverse outcomes, unlike elevated ALP which correlates with increased all-cause and cardiovascular mortality 6
• Low ALP can occur with nutritional deficiencies (zinc, magnesium), hypothyroidism, or certain medications, but in the absence of symptoms, no investigation is warranted 1
• The normal calcium and albumin exclude metabolic bone disease 1

Clinical Recommendations

No further investigation or intervention is needed based on these results 1:

• Guidelines recommend that abnormal liver blood tests should only be interpreted after review of previous results, past medical history, and current medical condition 1
• A standard liver aetiology screen (including hepatitis B/C serology, autoantibodies, ferritin/transferrin saturation, and abdominal ultrasound) is indicated only when there is a persistent pattern of abnormality or clinical suspicion of liver disease 1
• The magnitude of a single mildly abnormal value does not mandate investigation—many patients with significant chronic liver disease (NAFLD, hepatitis C, alcohol-related disease) have only mild abnormalities or even normal values 1

Common Pitfalls to Avoid

• Do not repeat liver enzymes simply because one value is marginally elevated—this strategy is costly and does not exclude chronic liver disease, as conditions like NAFLD and hepatitis C can present with normal or minimally elevated enzymes 1
• Do not assume normal liver enzymes exclude liver disease—patients with significant fibrosis may have enzymes within the reference range 1
• Do not over-interpret the AST/ALT ratio when absolute values are near-normal—diagnostic ratios (such as those used in Wilson disease diagnosis) are only valid in the context of significant liver dysfunction 5